Phase II Study of Imatinib Mesylate for Philadelphia-Positive Acute Lymphocytic Leukemia.
Phase of Trial: Phase II
Latest Information Update: 28 Feb 2017
At a glance
- Drugs Imatinib (Primary)
- Indications Acute lymphoblastic leukaemia
- Focus Therapeutic Use
- Sponsors Novartis
- 28 Feb 2017 Last checked against ClinicalTrials.gov record.
- 12 Mar 2011 New trial record